Role of contrast-enhanced transesophageal echocardiography for detection of and scoring intrapulmonary vascular dilatation

Echocardiography

Volumn 27, Issue 10, 2010, Pages 1233-1237

  Fischer, Claudio Henrique ^a   Campos, Orlando ^a   Fernandes, Walnei Barbosa ^a   Kondo, Mario ^a   Souza, Francival Leite ^a   De Andrade, Jose Lazaro ^a   Carvalho, Antonio C Camargo ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

contrast echocardiography; hepatopulmonary syndrome; patent foramen ovale; pulmonary shunt; transesophageal echocardiograhy

Indexed keywords

SODIUM CHLORIDE;

ADULT; ARTERIAL OXYGEN TENSION; ARTICLE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART LEFT ATRIUM; HEPATOPULMONARY SYNDROME; HUMAN; INTRAPULMONARY VASCULAR DILATATION; LIVER CIRRHOSIS; LUNG ALVEOLUS OXYGEN TENSION; LUNG CIRCULATION; LUNG GAS EXCHANGE; MAJOR CLINICAL STUDY; MALE; MICROBUBBLE; MICROCIRCULATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY SHUNT; SCORING SYSTEM; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; VASODILATATION;

CONTRAST MEDIA; DILATATION, PATHOLOGIC; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FEMALE; HEPATOPULMONARY SYNDROME; HUMANS; MALE; MICROBUBBLES; MIDDLE AGED; MODELS, BIOLOGICAL; PULMONARY ARTERY; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 78649666867     PISSN: 07422822     EISSN: 15408175     Source Type: Journal    
DOI: 10.1111/j.1540-8175.2010.01228.x     Document Type: Article

References (37)

1. Krowka MJ, Cortese DA,: Severe hypoxemia associated with liver disease: Mayo Clinic experience and expertal use of almitrine bismesylate. Mayo Clin Proc 1987; 62: 164-173.
2. McFaul RC, Tajik AJ, Mair DD, et al,: Development of pulmonary arteriovenous shunt after superior vena cava-right pulmonary artery (Glenn) anastomosis. Circulation 1977; 55: 212-216.
3. Marianeschi SM, McElhinney DB, Reddy VM,: Pulmonary arteriovenous malformations in and out of the setting of congenital heart disease. Ann Thorac Surg 1998; 66: 688-691.
4. Castro PF, Bourge RC, McGiffin DC, et al,: Intrapulmonary shunting in primary pulmonary hypertension. An observation in two patients treated with epoprostenol sodium. Chest 1998; 114: 334-336.
5. Cloutier A, Ash JM, Smallhorn JF, et al,: Abnormal distribution of pulmonary blood flow after the Glenn shunt or Fontan procedure: Risk of development of arteriovenous fistulae. Circulation 1985; 72: 471-479.
6. Colle I, Van Steenkiste C, Geerts A, et al,: Hepatopulmonary syndrome and portopulmonary hypertension: What's new? Acta Gastroenterol Belg 2007; 70: 203-209.
7. Krowka MJ, Cortese DA,: Hepatopulmonary syndrome: An evolving perspective in the era of liver transplantation. Hepatology 1990; 11: 138-142.
8. Rodriguez-Roisin R, Krowka MJ, Herve Ph, et al,; on behalf of the ERS Task Force Pulmonary-Hepatic Vascular Disorders (PHD) Scientific Committee: Pulmonary-Hepatic vascular disorders (PHD). Eur Respir J 2004; 24: 861-880.
9. Srivastava D, Preminger T, Lock JE, et al,: Hepatic venous blood and the development of pulmonary arteriovenous malformations in congenital heart disease. Circulation 1995; 92: 1217-1222.
10. Vallance P, Moncada S,: Hyperdynamic circulation in cirrhosis: A role for nitric oxide? Lancet 1991; 337: 776-778.
11. Krowka MJ, Cortese DA,: Hepatopulmonary syndrome. Current concepts in diagnostic and therapeutic considerations. Chest 1994; 105: 1528-1537.
12. Sogni P, Moreau R, Gadano A, et al,: The role of nitric oxide in the hyperdinamic circulatory syndrome associated with portal hypertension. J Hepatol 1995; 23: 218-224.
13. Cremona G, Higenbottam TW, Mayoral V, et al,: Elevated exhaled nitric oxide in patients with hepatopulmonary syndrome. Eur Respir J 1995; 8: 1883-1885.
14. Rodriguez-Roisin R, Barberà JÁ: Hepatopulmonary syndrome: Is NO the right answer?[Editorial]. Gastroenterology 1997; 113: 682-684.
15. Fallon MB, Abrams GA, Luo B, et al,: The role of endothelial nitric oxide synthase in the pathogenesis of a rat model of hepatopulmonary syndrome. Gastroenterology 1997; 113: 606-614.
16. Rolla G, Brussino L, Colagrande P, et al,: Exhaled nitric oxide and impaired oxygenation in cirrhotic patients before and after liver transplantation. Ann Intern Med 1998; 129: 75-78.
17. Barbe T, Losay J, Grimon G, et al,: Pulmonary arteriovenous shunting in children with liver disease. J Pediatr 1995; 126: 571-579.
18. Lange PA, Stoller JK,: The hepatopulmonary syndrome. Ann Intern Med 1995; 122: 521-529.
19. Seward JB, Khandheria BK, Oh JK, et al,: Transesophageal echocardiography: Technique, anatomic correlations, implementation, and clinical applications. Mayo Clin Proc 1988; 63: 649-680.
20. Shub C, Tajik AJ, Seward JB, et al,: Detecting intrapulmonary right to left shunting with contrast echocardiography: Observations in a patient with diffuse pulmonary arteriovenous fistulas. Mayo Clin Proc 1976; 51: 81-84.
21. Siostrzonek P, Zangeneh M, Gössinger H, et al,: Comparison of transesophageal and transthoracic contrast echocardiography for detection of a patent foramen ovale. Am J Cardiol 1991; 68: 1247-1249.
22. Vedrinne J-M, Duperret S, Bizollon T, et al,: Comparison of transesophageal and transthoracic contrast echocardiography for detection of an intrapulmonary shunt in liver disease. Chest 1997; 111: 1236-1240.
23. Schenk P, Fuhrmann V, Madl C, et al,: Hepatopulmonary syndrome: Prevalence and predictive value of various cut offs for arterial oxygenation and their clinical consequences. Gut 2002; 51: 853-859.
24. Aller R, Moya JL, Moreira V, et al,: Diagnosis and grading of intrapulmonary vascular dilatation in cirrhotic patients with contrast transesophageal echocardiography. J Hepatol 1999; 31: 1044-1052.
25. Hind CRK, Wong CM,: Detection of pulmonary arteriovenous fistulae in patient with cirrhosis by contrast 2D echocardiography. Gut 1981; 22: 1042-1045.
26. Butler BD, Hills BA,: The lung as a filter for microbubbles. J Appl Physiol 1979; 47: 537-543.
27. Moya Mur JL, Aller R, Catalán P, et al,: Utilidad de la ecocardiografia de contraste en la valoración del tamaño capilar pulmonar. Rev Esp Cardiol 1997; 50: 98-102.
28. Henig NR, Pierson DJ,: Mechanisms of hypoxemia. Respir Care Clin N Am 2000; 6: 501-521.
29. Peyton PJ, Robinson GJ, McCall PR, et al,: Noninvasive measurement of intrapulmonary shunting. J Cardiothorac Vasc Anesth 2004; 18: 47-52.
30. Hopkins WE, Waggoner AD, Barzilai B,: Frequency and significance of intrapulmonary right-to-left shunting in end-stage hepatic disease. Am J Cardiol 1992; 70: 51-59.
31. Aller R, Moreira V, Boixeda D, et al,: Diagnosis of hepatopulmonary syndrome with contrast transthoracic echocardiography and histological confirmation. Liver 1998; 18: 285-287.
32. Abrams GA, Jaffe CC, Hoffer PB, et al,: Diagnostic utility of contrast echocardiography and lung perfusion scan in patients with hepatopulmonary syndrome. Gastroenterology 1995; 109: 1283-1288.
33. Aller R, Moya JL, Moreira V, et al,: Diagnosis of hepatopulmonary syndrome with contrast transesophageal echocardiography. Advantages over contrast transthoracic echocardiography. Dig Dis Sci 1999; 44: 1243-1248.
34. Pavarino PR, Corbucci HAR, Marchi CH, et al,: Contrast echocardiography in the diagnosis of intrapulmonary vascular dilations in patients eligible for liver transplantation. Arq Bras Cardiol 2004; 82: 332-336.
35. Rodriguez-Roisin R, Agusti AGN, Roca J,: The hepatopulmonary syndrome: New name, old complexities. Thorax 1992; 47: 897-902.
36. Schiffer E, Majno P, Mentha G, et al,: Hepatopulmonary syndrome increases the postoperative mortality rate following liver transplantation: A prospective study in 90 patients. Am J Transplant 2006; 6: 1430-1437.
37. Spier BJ, Larue SJ, Teelin TC, et al,: Review of complications in a series of patients with known gastro-esophageal varices undergoing transesophafeal echocardiography. J Am Soc Echocardiogr 2009; 22: 396-400.